Could read many ways. Obvious part is ATT has a big percentage of the company that will be hard to sell in the market piecemeal.
If commercialization of Mente Autism takes traction and advancement into FDA approval, a stake sale into a bigger medical device corporation to push the product further would be an easier way for ATT to exit and will also impact the company more positively.
Ann: Board Change, page-4
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
